Karyopharm Therapeutics
KPTI
KPTI
153 hedge funds and large institutions have $608M invested in Karyopharm Therapeutics in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 54 increasing their positions, 56 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
11% less funds holding
Funds holding: 171 → 153 (-18)
45% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 38
67% less call options, than puts
Call options by funds: $4.62M | Put options by funds: $14.1M
Holders
153
Holding in Top 10
1
Calls
$4.62M
Puts
$14.1M
Top Buyers
| 1 | +$43.9M | |
| 2 | +$10.6M | |
| 3 | +$5.64M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$5M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$3.96M |
Top Sellers
| 1 | -$14.2M | |
| 2 | -$13.6M | |
| 3 | -$9.49M | |
| 4 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
-$8.73M |
| 5 |
Two Sigma Investments
New York
|
-$6.67M |